azacitidine has been researched along with Canine Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujino, Y; Fujiwara-Igarashi, A; Goto-Koshino, Y; Mochizuki, H; Ohno, K; Sato, M; Tsujimoto, H | 1 |
| Haraguchi, T; Itamoto, K; Mizuno, T; Mori, T; Nakagawa, T; Noguchi, S | 1 |
2 other study(ies) available for azacitidine and Canine Diseases
| Article | Year |
|---|---|
Inhibition of p16 tumor suppressor gene expression via promoter hypermethylation in canine lymphoid tumor cells.
Topics: Animals; Azacitidine; Base Sequence; Cell Line, Tumor; CpG Islands; Cyclin-Dependent Kinase Inhibitor p16; DNA Methylation; DNA Primers; Dog Diseases; Dogs; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Genes, Tumor Suppressor; Lymphoma; Molecular Sequence Data; Promoter Regions, Genetic | 2014 |
DNA methylation contributes toward silencing of antioncogenic microRNA-203 in human and canine melanoma cells.
Topics: Animals; Azacitidine; Cell Line, Tumor; Cells, Cultured; DNA Methylation; Dog Diseases; Dogs; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Tumor Suppressor; Humans; Melanocytes; Melanoma; MicroRNAs; Mouth Neoplasms | 2015 |